Literature DB >> 28745721

Helping EGFR inhibition to block cancer.

Rolf Warta1, Christel Herold-Mende1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28745721     DOI： 10.1038/nn.4605

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN： 1097-6256            Impact factor:   24.884


× No keyword cloud information.
  10 in total

1.  Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

Authors:  John H Sampson; Amy B Heimberger; Gary E Archer; Kenneth D Aldape; Allan H Friedman; Henry S Friedman; Mark R Gilbert; James E Herndon; Roger E McLendon; Duane A Mitchell; David A Reardon; Raymond Sawaya; Robert J Schmittling; Weiming Shi; James J Vredenburgh; Darell D Bigner
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

2.  Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.

Authors:  N Sugawa; A J Ekstrand; C D James; V P Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  The somatic genomic landscape of glioblastoma.

Authors:  Cameron W Brennan; Roel G W Verhaak; Aaron McKenna; Benito Campos; Houtan Noushmehr; Sofie R Salama; Siyuan Zheng; Debyani Chakravarty; J Zachary Sanborn; Samuel H Berman; Rameen Beroukhim; Brady Bernard; Chang-Jiun Wu; Giannicola Genovese; Ilya Shmulevich; Jill Barnholtz-Sloan; Lihua Zou; Rahulsimham Vegesna; Sachet A Shukla; Giovanni Ciriello; W K Yung; Wei Zhang; Carrie Sougnez; Tom Mikkelsen; Kenneth Aldape; Darell D Bigner; Erwin G Van Meir; Michael Prados; Andrew Sloan; Keith L Black; Jennifer Eschbacher; Gaetano Finocchiaro; William Friedman; David W Andrews; Abhijit Guha; Mary Iacocca; Brian P O'Neill; Greg Foltz; Jerome Myers; Daniel J Weisenberger; Robert Penny; Raju Kucherlapati; Charles M Perou; D Neil Hayes; Richard Gibbs; Marco Marra; Gordon B Mills; Eric Lander; Paul Spellman; Richard Wilson; Chris Sander; John Weinstein; Matthew Meyerson; Stacey Gabriel; Peter W Laird; David Haussler; Gad Getz; Lynda Chin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 4.  Targeted molecular therapies against epidermal growth factor receptor: past experiences and challenges.

Authors:  David A Reardon; Patrick Y Wen; Ingo K Mellinghoff
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

5.  A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma.

Authors:  Manfred Westphal; Oliver Heese; Joachim P Steinbach; Oliver Schnell; Gabriele Schackert; Maximilian Mehdorn; Dirk Schulz; Matthias Simon; Uwe Schlegel; Christian Senft; Karsten Geletneky; Christian Braun; Joachim G Hartung; Dirk Reuter; Monika Warmuth Metz; Ferdinand Bach; Torsten Pietsch
Journal:  Eur J Cancer       Date:  2015-01-20       Impact factor: 9.162

6.  De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients.

Authors:  David Akhavan; Alexandra L Pourzia; Alex A Nourian; Kevin J Williams; David Nathanson; Ivan Babic; Genaro R Villa; Kazuhiro Tanaka; Ali Nael; Huijun Yang; Julie Dang; Harry V Vinters; William H Yong; Mitchell Flagg; Fuyuhiko Tamanoi; Takashi Sasayama; C David James; Harley I Kornblum; Tim F Cloughesy; Webster K Cavenee; Steven J Bensinger; Paul S Mischel
Journal:  Cancer Discov       Date:  2013-03-26       Impact factor: 39.397

7.  Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor.

Authors:  R B Montgomery; D K Moscatello; A J Wong; J A Cooper; W L Stahl
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

8.  Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma.

Authors:  Paul H Huang; Akitake Mukasa; Rudy Bonavia; Ryan A Flynn; Zachary E Brewer; Webster K Cavenee; Frank B Furnari; Forest M White
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-23       Impact factor: 11.205

9.  Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.

Authors:  Arezu Jahani-Asl; Hang Yin; Vahab D Soleimani; Takrima Haque; H Artee Luchman; Natasha C Chang; Marie-Claude Sincennes; Sidharth V Puram; Andrew M Scott; Ian A J Lorimer; Theodore J Perkins; Keith L Ligon; Samuel Weiss; Michael A Rudnicki; Azad Bonni
Journal:  Nat Neurosci       Date:  2016-04-25       Impact factor: 24.884

10.  EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.

Authors:  Eskil Eskilsson; Gro V Rosland; Krishna M Talasila; Stian Knappskog; Olivier Keunen; Andrea Sottoriva; Sarah Foerster; Gergely Solecki; Torfinn Taxt; Radovan Jirik; Sabrina Fritah; Patrick N Harter; Kristjan Välk; Jubayer Al Hossain; Justin V Joseph; Roza Jahedi; Halala S Saed; Sara G Piccirillo; Inma Spiteri; Lina Leiss; Philipp Euskirchen; Grazia Graziani; Thomas Daubon; Morten Lund-Johansen; Per Øyvind Enger; Frank Winkler; Christoph A Ritter; Simone P Niclou; Colin Watts; Rolf Bjerkvig; Hrvoje Miletic
Journal:  Neuro Oncol       Date:  2016-06-10       Impact factor: 12.300
  10 in total
  4 in total

1.  Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma.

Authors:  Gao Guo; Ke Gong; Vineshkumar Thidil Puliyappadamba; Nishah Panchani; Edward Pan; Bipasha Mukherjee; Ziba Damanwalla; Sabrina Bharia; Kimmo J Hatanpaa; David E Gerber; Bruce E Mickey; Toral R Patel; Jann N Sarkaria; Dawen Zhao; Sandeep Burma; Amyn A Habib
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

2.  TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer.

Authors:  Ke Gong; Gao Guo; David E Gerber; Boning Gao; Michael Peyton; Chun Huang; John D Minna; Kimmo J Hatanpaa; Kemp Kernstine; Ling Cai; Yang Xie; Hong Zhu; Farjana J Fattah; Shanrong Zhang; Masaya Takahashi; Bipasha Mukherjee; Sandeep Burma; Jonathan Dowell; Kathryn Dao; Vassiliki A Papadimitrakopoulou; Victor Olivas; Trever G Bivona; Dawen Zhao; Amyn A Habib
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

3.  EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer.

Authors:  Ke Gong; Gao Guo; Nishah Panchani; Matthew E Bender; David E Gerber; John D Minna; Farjana Fattah; Boning Gao; Michael Peyton; Kemp Kernstine; Bipasha Mukherjee; Sandeep Burma; Cheng-Ming Chiang; Shanrong Zhang; Adwait Amod Sathe; Chao Xing; Kathryn H Dao; Dawen Zhao; Esra A Akbay; Amyn A Habib
Journal:  Nat Cancer       Date:  2020-04-06

4.  Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue.

Authors:  Sander Bekeschus; Mikael Ispirjan; Eric Freund; Frederik Kinnen; Juliane Moritz; Fariba Saadati; Jacqueline Eckroth; Debora Singer; Matthias B Stope; Kristian Wende; Christoph A Ritter; Henry W S Schroeder; Sascha Marx
Journal:  Cancers (Basel)       Date:  2022-02-05       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.